EUVIMEDEUVIMED entdecken
Crossref

Long-term outcome of lung Retransplantation for chronic lung allograft dysfunction after En-bloc heart and lung transplantation

Marien Lenoir iD, Brendan Le Picault iD, Justin Issard, Delphine Mitilian, Jean-Baptiste Menager, Dominique Fabre, Iolanda Ion, François Stephan, Gaëlle Dauriat, Jérôme Le Pavec, Olaf Mercier iD, Elie Fadel

European Journal of Cardio-Thoracic Surgery · 2026

DOI: 10.1093/ejcts/ezag094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2026. Verfasst von Marien Lenoir und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery and Heart-Lung Transplantation, Marie-Lannelongue Hospital, Le Plessis Robinson 92350, France. Hauptthemen laut MEDLINE: Reoperation, Lung Transplantation, Heart-Lung Transplantation, Primary Graft Dysfunction.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES CLAD is a major factor limiting long-term survival after heart-lung transplantation (HLTx). Whether lung retransplantation (LRTx) offers the same long-term results in HLTx recipients as in DLTx recipients remains unknown. The aim of this study was to compare outcomes of LRTx after HLTx and DLTx. METHODS We retrospectively reviewed charts of patients retransplanted at our institution in 2006–2023. Outcomes after LRTx, overall survival, and BOS-free survival were compared between HLTx and DLTx groups. RESULTS LRTx was performed in 60 patients, including 20 after HLTx and 40 after DLTx. Median post-retransplant follow-up was 3.54 years [1.37—6.79]. Median time to retransplantation was significantly shorter in LRTx group (HLTx: 5.47 [4.55—7.02] years vs DLTx: 2.77 [1.55—5.46] years; P = 0.03). Overall in-hospital mortality was 5% (n = 3) with no significant difference between the groups. The two groups were similar for PGD Grade 2 or 3 at 72 h (HLTx: 17%; DLTx: 39%; P = 0.133), 1- and 5-year overall survival (HLTx: 70% and 54%; DLTx: 87% and 43%; P = 0.249) and 1- and 5-year BOS-free survival rates (HLTx: 70% and 40%; DLTx: 72% and 33%; P = 0.402). With LRTx after HLTx, 10-year freedom from coronary allograft vasculopathy (CAV) since the first transplant was 72%. CONCLUSIONS Overall survival and BOS-free survival benefits of LRTx were similar after DLTx or HLTx. LRTx in HLTx group did not lead to an increased risk of CAV. LRTx seems a good option for carefully selected patients with end-stage CLAD after HLTx to improve survival and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ReoperationLung TransplantationHeart-Lung TransplantationPrimary Graft DysfunctionHumansFemaleMaleRetrospective StudiesAdultMiddle AgedTreatment OutcomeAllograftsChronic DiseaseBronchiolitis Obliterans SyndromeFollow-Up Studies

Stichwörter der Autor:innen

chronic lung allograft dysfunctiondouble-lung transplantationheart and lung transplantationretransplantation

Autor:innen und Institutionen

  • Department of Thoracic Surgery and Heart-Lung Transplantation, Marie-Lannelongue Hospital, Le Plessis Robinson 92350, France.
  • Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, 94250, France.
  • Department of Anesthesiology and Intensive Care Unit, Marie-Lannelongue Hospital, Le Plessis Robinson, 92350, France.
  • Department of Respirology, Marie-Lannelongue Hospital, Le Plessis Robinson, 92350, France.

ORCID-Profile: Marien Lenoir, Brendan Le Picault, Olaf Mercier

Zitieren

APA

Lenoir, M., Le Picault, B., Issard, J., Mitilian, D., Menager, J. B., Fabre, D., Ion, I., Stephan, F., Dauriat, G., Le Pavec, J., Mercier, O., & Fadel, E. (2026). Long-term outcome of lung Retransplantation for chronic lung allograft dysfunction after En-bloc heart and lung transplantation. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezag094

Vancouver

Lenoir M, Le Picault B, Issard J, Mitilian D, Menager JB, Fabre D, et al. Long-term outcome of lung Retransplantation for chronic lung allograft dysfunction after En-bloc heart and lung transplantation. European Journal of Cardio-Thoracic Surgery. 2026. doi:10.1093/ejcts/ezag094

BibTeX
@article{Lenoir2026,
  author = {Lenoir, Marien and Le Picault, Brendan and Issard, Justin and Mitilian, Delphine and Menager, Jean-Baptiste and Fabre, Dominique and Ion, Iolanda and Stephan, François and Dauriat, Gaëlle and Le Pavec, Jérôme and Mercier, Olaf and Fadel, Elie},
  title = {Long-term outcome of lung Retransplantation for chronic lung allograft dysfunction after En-bloc heart and lung transplantation},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2026},
  doi = {10.1093/ejcts/ezag094}
}
Kostenlos starten →